Cart
sales@molnova.com
WY-47766
CAS No. 134217-27-9
WY-47766( —— )
Catalog No. M34472 CAS No. 134217-27-9
WY-47766 (OST-766) is a small molecule proton pump inhibitor that can be used to study postmenopausal osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 411 | In Stock |
|
| 10MG | 562 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWY-47766
-
NoteResearch use only, not for human use.
-
Brief DescriptionWY-47766 (OST-766) is a small molecule proton pump inhibitor that can be used to study postmenopausal osteoporosis.
-
DescriptionWY-47766(OST-766) is aproton pumpinhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetProton Pump
-
RecptorProton pump
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number134217-27-9
-
Formula Weight287.34
-
Molecular FormulaC14H13N3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(C1=NC=2C=NC=CC2N1)CC=3C=CC=C(OC)C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Farina C, et al. Selective inhibition of osteoclast vacuolar H(+)-ATPase. Curr Pharm Des. 2002;8(23):2033-2048.?
molnova catalog
related products
-
Tegoprazan
A novel potent, highly selective, competitive and orally active inhibitor of gastric H+/K+-ATPase with IC50 of ranging 0.29-0.52 uM porcine, canine and human H+/K+-ATPases in vitro.
-
R-(+)-Lansoprazole
Dexlansoprazole is a Proton Pump Inhibitor.
-
TAK-438 free base
A novel potent, oral potassium-competitive acid blocker (P-CAB) that potently inhibits H+,K+-ATPase with IC50 of 19 nM.
